Lifevantage Debt to Equity Ratio 2010-2024 | LFVN

Current and historical debt to equity ratio values for Lifevantage (LFVN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Lifevantage debt/equity for the three months ending September 30, 2024 was 0.00.
Lifevantage Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.03B $0.03B 1.22
2024-06-30 $0.03B $0.03B 1.32
2024-03-31 $0.04B $0.03B 1.29
2023-12-31 $0.04B $0.03B 1.30
2023-09-30 $0.04B $0.03B 1.27
2023-06-30 $0.03B $0.04B 0.91
2023-03-31 $0.03B $0.03B 1.01
2022-12-31 $0.04B $0.03B 1.13
2022-09-30 $0.04B $0.03B 1.12
2022-06-30 $0.04B $0.03B 1.24
2022-03-31 $0.04B $0.03B 1.12
2021-12-31 $0.04B $0.04B 1.08
2021-09-30 $0.04B $0.04B 1.03
2021-06-30 $0.04B $0.04B 1.14
2021-03-31 $0.04B $0.04B 1.11
2020-12-31 $0.04B $0.04B 1.10
2020-09-30 $0.04B $0.03B 1.06
2020-06-30 $0.03B $0.03B 0.77
2020-03-31 $0.02B $0.03B 0.83
2019-12-31 $0.03B $0.03B 0.89
2019-09-30 $0.03B $0.03B 0.89
2019-06-30 $0.03B $0.03B 1.03
2019-03-31 $0.03B $0.03B 1.19
2018-12-31 $0.03B $0.02B 1.57
2018-09-30 $0.03B $0.02B 1.21
2018-06-30 $0.03B $0.02B 1.33
2018-03-31 $0.03B $0.02B 1.64
2017-12-31 $0.03B $0.02B 1.77
2017-09-30 $0.03B $0.02B 1.84
2017-06-30 $0.03B $0.02B 2.12
2017-03-31 $0.03B $0.01B 2.36
2016-12-31 $0.03B $0.02B 2.21
2016-09-30 $0.04B $0.01B 2.54
2016-06-30 $0.04B $0.01B 3.78
2016-03-31 $0.04B $0.01B 3.99
2015-12-31 $0.04B $0.01B 5.41
2015-09-30 $0.04B $0.01B 7.65
2015-06-30 $0.04B $0.00B 10.96
2015-03-31 $0.04B $0.00B 15.58
2014-12-31 $0.05B $0.01B 10.23
2014-09-30 $0.05B $0.01B 6.88
2014-06-30 $0.05B $0.00B 12.53
2014-03-31 $0.07B $0.00B 24.78
2013-12-31 $0.06B $-0.00B -116.68
2013-09-30 $0.02B $0.04B 0.55
2013-06-30 $0.02B $0.03B 0.64
2013-03-31 $0.02B $0.04B 0.56
2012-12-31 $0.02B $0.04B 0.57
2012-09-30 $0.02B $0.03B 0.47
2012-06-30 $0.02B $0.03B 0.57
2012-03-31 $0.01B $0.02B 0.48
2011-12-31 $0.02B $0.01B 1.64
2011-09-30 $0.03B $-0.02B -2.06
2011-06-30 $0.03B $-0.02B -1.60
2011-03-31 $0.02B $-0.01B -1.73
2010-12-31 $0.01B $-0.01B -2.63
2010-09-30 $0.02B $-0.01B -1.61
2010-06-30 $0.02B $-0.02B -1.39
2010-03-31 $0.02B $-0.01B -1.50
2009-12-31 $0.01B $-0.01B -1.88
2009-09-30 $0.01B $-0.01B -1.86
2009-06-30 $0.01B $-0.01B -1.84
2009-03-31 $0.01B $-0.00B -2.35
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.178B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.746B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Pro-Dex (PDEX) United States $0.152B 30.36